Clariant in the news

Clariant's sale of its small Venezuelan business causes a 236 million franc loss due to currency effects, threatening its 2025 profit outlook.

CMV Química acquired Clariant Venezuela S.A. from Clariant AG for 1.4 million CHF, with the latter having 3 million CHF revenue and 60 employees in 2024.

Clariant is shrinking its Board of Directors and adding two independent members to improve governance and address investor concerns.

Clariant plans to add BP Chairman Albert Manifold to its board and is cutting costs amid legal disputes and awaiting demand growth.

Clariant, a Swiss specialty chemicals company, denies competition law violations while operating across Care Chemicals, Catalysis, and Natural Resources sectors.

Clariant's cautious 2025 outlook reflects weak industrial demand and margin risks, projecting modest growth and profit gains by 2028 amid market uncertainties.

Clariant's stock modestly increased to 6.88 CHF amid stable earnings and upcoming Q4 2025 results expected in February 2026.

Clariant is facing new billion-euro damage claims over an EU cartel case amid ongoing legal and financial troubles.

Clariant's stock fell 0.9% to 6.80 CHF, with stable recent revenue and a slightly lower dividend forecast for 2025.

Clariant rejects 2020 antitrust violation claims from MOL Group and Braskem involving four companies.

Clariant's stock showed moderate gains with stable past earnings and dividends, while upcoming Q4 2025 results are anticipated with an EPS forecast of 0.685 CHF.

Clariant's stock price dropped 35% over the past year, reducing a 10,000 CHF investment to about 6,493 CHF.

Clariant's cautious 2025 outlook reflects concerns over weak industrial demand and margin pressures, with modest growth expected through 2028.

A 10,000 CHF investment in Clariant stock 10 years ago would have lost over half its value by 2025, dropping from 15.67 CHF to 7.20 CHF per share.

Clariant's stock fell 1.6% to 6.92 CHF amid stable earnings and upcoming Q4 2025 results, with a recent 52-week high of 10.96 CHF.

Clariant sold its Venezuelan specialty chemicals business to CMV Química for around 1.8 million USD.

Clariant is sued for €950 million over alleged ethylene price-fixing, which it denies, amid multiple similar lawsuits against major chemical firms.

Clariant is selling its Venezuela business for $1.8 million, impacting 2025 net profit due to currency differences but not cash flow or EBITDA forecasts, amid rising US-Venezuela tensions.

Clariant is exiting its declining Venezuelan business, selling it at a loss due to currency effects, but maintains its core profitability outlook.

Clariant reported a 9% revenue drop in Q3 2025, lowered its growth forecast, but improved EBITDA margins and confirmed mid-term targets.